SCHEMBL21717119

SCHEMBL21717119

c1ccc2c(c1)cc(-c1nc(-n3c4ccccc4c4cc5cc(-n6c7ccccc7c7ccccc76)ccc5cc43)nc3ccccc13)c1ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.36
KDM4E B2RXH2 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
ATM Q13315 1/20 0.33
POLB P06746 1/20 0.33
ALDH1A1 P00352 3/20 0.32
MAPT P10636 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
F2 P00734 1/20 0.32
F10 P00742 1/20 0.32
PRSS1 P07477 1/20 0.32
HSD17B10 Q99714 1/20 0.31
LMNA P02545 1/20 0.30
PRKCB P05771 1/20 0.30
PRKCA P17252 1/20 0.30
PRKCH P24723 1/20 0.30
PRKCE Q02156 1/20 0.30
PRKCQ Q04759 1/20 0.30
PRKCD Q05655 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21717222 1.00 HPGD (0.36) HPGDKDM4EL3MBTL1ATMPOLB
SCHEMBL21716938 0.93 HPGD (0.33) HPGDF2F10PRSS1
SCHEMBL21213402 0.92 KDM4E (0.37) HPGDKDM4EL3MBTL1ATMPOLB
SCHEMBL21717426 0.92 HPGD (0.33) HPGDPOLBF2F10PRSS1
SCHEMBL20391585 0.90 KDM4E (0.40) HPGDKDM4EL3MBTL1ATMALDH1A1
SCHEMBL21168906 0.90 KDM4E (0.40) HPGDKDM4EL3MBTL1ATMALDH1A1
SCHEMBL21161123 0.90 L3MBTL1 (0.37) HPGDKDM4EL3MBTL1ATMPOLB
SCHEMBL21716523 0.87 HPGD (0.36) HPGDKDM4EL3MBTL1ATMPOLB
SCHEMBL21716573 0.87 HPGD (0.36) HPGDKDM4EL3MBTL1ATMPOLB
SCHEMBL21717481 0.86 KDM4E (0.46) HPGDKDM4EL3MBTL1ATMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 HPGD 652/4885KDM4E 1813/4885L3MBTL1 1427/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 HPGD 652/4885KDM4E 1813/4885L3MBTL1 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.